Showing results (141-150 of 154) with videos related to
Sort By:
Pageof 16
Journal of Clinical Anesthesia|March 8, 2011
Analgesic efficacy of ultrasound-guided regional anesthesia: a meta-analysisHarold J Gelfand, Jean-Pierre P Ouanes, Maggie R Lesley, et al.Drug Design and Discovery|August 6, 2000
Substituted 3-phenylsulfonylquinazoline-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymaseH Fukami, S Imajo, A Ito, et al.Immunology|November 30, 2005
Evaluation of CD62L expression as a marker for vaccine-elicited memory cytotoxic T lymphocytesShawn S Jackson, Jörn E Schmitz, Marcelo J Kuroda, et al.Journal of Virology|July 30, 2003
Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccinesDan H Barouch, Paul F McKay, Shawn M Sumida, et al.The Journal of Clinical Investigation|November 3, 2004
Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccinesShawn M Sumida, Paul F McKay, Diana M Truitt, et al.Journal of Virology|July 5, 2005
A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primatesDan H Barouch, Zhi-yong Yang, Wing-pui Kong, et al.Journal of Virology|July 15, 2005
Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunityAngelique A C Lemckert, Shawn M Sumida, Lennart Holterman, et al.Journal of Virology|March 3, 2004
Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectorsShawn M Sumida, Diana M Truitt, Michael G Kishko, et al.Journal of Virology|October 29, 2005
Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeysAnjali Nanda, Diana M Lynch, Jaap Goudsmit, et al.Journal of Medicinal Chemistry|July 4, 1997
Substituted 3-(phenylsulfonyl)-1-phenylimidazolidine-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymaseS Niwata, H Fukami, M Sumida, et al.Pageof 16